| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |